NCT06728176View on ClinicalTrials.gov

Safety and PK of Multiple Doses of MT1988

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

April 8, 2025

Study Completion Date

April 10, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

MT1988

Active Drug

DRUG

Placebo

Placebo comparator

Trial Locations (1)

G4 0SF

BDD Pharma Ltd, Glasgow

Sponsors
All Listed Sponsors
lead

Monument Therapeutics Limited

INDUSTRY

NCT06728176 - Safety and PK of Multiple Doses of MT1988 | Biotech Hunter | Biotech Hunter